AZ to Shuffle Sales, Marketing Units, Focus on 3 Disease Areas

AstraZeneca K.K. (AZ) announced on June 12 that it will shift to a new sales and marketing structure on July 1 focusing on three disease areas: cardiovascular and metabolic, gastrointestinal and RIA (respiratory, inflammation, and autoimmune), and oncology. By conforming...read more